Neucore Bio
Columbus, US · 7 employees on LinkedIn · 1 known investors
Find your way into Neucore Bio
148 people in our graph share verified history with the Neucore Bio team — schools, employers, funds. One of them is your warm intro.
Emma Offunlockedknows Peter Kleinhenz · together at Clarametyx Biosciences (overlapped)
×8knows the team · via Case Western Reserve University
×2knows the team · via Neucore Bio
knows the team · via Loyola University Chicago
Neucore Bio develops precision therapeutics using engineered exosomes derived from fibroblasts to deliver molecular-level cellular repair and renewal across genetic and degenerative diseases with high unmet medical needs.
Founders & leadership
BP
Brian Price, Ph.D.Co-founder / Chief Executive Officer
PK
Peter KleinhenzinCo-founder / Board ChairPeter Kleinhenz is co-founder and board chair of Neucore Bio and managing director of Woodhall Consulting, LLC, advising early-stage life science companies on strategy, fundraising, and commercialization. He has held C-suite leadership and board governance roles at multiple biotech companies.
MT
Michael Triplett, Ph.D.Co-founder / Board Chair
KL
Kenneth L. Morand, Ph.D.Co-founder and Board Member
DG
Daniel Gallego-Perez, Ph.D.Scientific Co-founder
NH
Natalia Higuita-Castro, Ph.D.Scientific Co-founder
Investors · 1
Competitors · 5
by search overlap
Neion Bio9 shared keywordsNeion Bio uses genetic engineering to turn chicken eggs into production systems for recombinant biologic proteins.
RenBio9 shared keywordsRenBio develops DNA-based therapeutic technology that uses intramuscular injection of therapeutic-encoding "bioblueprints" so a patient's own muscle cells produce antibodies and therapeutic proteins to prevent and treat diseases, including infectious diseases. The company works in the antibody and therapeutic protein field, aiming to overcome obstacles in delivery, durability, and cost.
Engage Bio9 shared keywordsEngageBio develops DNA-based medicines using proprietary non-viral delivery technology to achieve extended therapeutic expression from a single dose with low manufacturing complexity.
Bioworld8 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Syndeio Biosciences7 shared keywordsSyndeio Biosciences is a synapse-focused biotech developing precision neurotherapeutics for neuropsychiatric, mental health, and cognitive disorders such as depression and Alzheimer's. Its proprietary Boost Platform models synapse pharmacology, and its pipeline includes NMDA receptor positive allosteric modulators (zelquistinel and apimostinel) in Phase 2 clinical trials.
Companies competing with Neucore Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Neucore Bio do?
- Neucore Bio develops precision therapeutics using engineered exosomes derived from fibroblasts to deliver molecular-level cellular repair and renewal across genetic and degenerative diseases with high unmet medical needs.
- Who founded Neucore Bio?
- Neucore Bio was founded by Brian Price, Ph.D., Peter Kleinhenz, Michael Triplett, Ph.D., Kenneth L. Morand, Ph.D., Daniel Gallego-Perez, Ph.D., Natalia Higuita-Castro, Ph.D..
- Who are Neucore Bio's investors?
- Neucore Bio's investors include CincyTech.
- Where is Neucore Bio headquartered?
- Neucore Bio is headquartered in Columbus, US.